Renaissance Technologies LLC boosted its stake in Petmed Express Inc (NASDAQ:PETS) by 15.6% in the second quarter, Holdings Channel.com reports. The firm owned 1,914,915 shares of the company’s stock after acquiring an additional 259,100 shares during the quarter. Renaissance Technologies LLC owned about 0.09% of Petmed Express worth $30,007,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. LSV Asset Management grew its stake in Petmed Express by 35.0% during the first quarter. LSV Asset Management now owns 762,337 shares of the company’s stock worth $17,366,000 after buying an additional 197,550 shares during the period. Bank of New York Mellon Corp grew its stake in Petmed Express by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 456,011 shares of the company’s stock worth $7,146,000 after buying an additional 12,917 shares during the period. Rothschild Investment Corp IL grew its stake in Petmed Express by 55.7% during the second quarter. Rothschild Investment Corp IL now owns 182,328 shares of the company’s stock worth $2,857,000 after buying an additional 65,208 shares during the period. Allianz Asset Management GmbH grew its stake in Petmed Express by 6.1% during the second quarter. Allianz Asset Management GmbH now owns 177,193 shares of the company’s stock worth $2,777,000 after buying an additional 10,160 shares during the period. Finally, North Star Investment Management Corp. grew its stake in Petmed Express by 15.0% during the second quarter. North Star Investment Management Corp. now owns 153,743 shares of the company’s stock worth $2,409,000 after buying an additional 20,004 shares during the period. Hedge funds and other institutional investors own 97.46% of the company’s stock.
Several research firms have issued reports on PETS. Craig Hallum downgraded shares of Petmed Express from a “buy” rating to a “hold” rating and set a $15.00 price objective for the company. in a research note on Friday, August 16th. BidaskClub upgraded shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st.
PETS traded up $0.51 during trading on Friday, hitting $18.47. 714,686 shares of the company’s stock were exchanged, compared to its average volume of 607,231. Petmed Express Inc has a 1 year low of $15.00 and a 1 year high of $37.52. The stock has a 50 day moving average price of $16.23 and a 200 day moving average price of $18.71. The firm has a market cap of $362.54 million, a P/E ratio of 12.14 and a beta of 0.56.
Petmed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, July 22nd. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by ($0.16). Petmed Express had a return on equity of 23.42% and a net margin of 11.05%. The business had revenue of $79.99 million for the quarter, compared to analysts’ expectations of $85.83 million. During the same quarter in the prior year, the firm earned $0.62 earnings per share. Petmed Express’s quarterly revenue was down 8.5% compared to the same quarter last year.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Story: Is it Safe to Invest in Commodities?
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.